Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: A. Charles who wrote (530)	8/2/2001 5:40:51 PM
From: All Mtn Ski	Read Replies (1) \| Respond to of 548

I dunno what will happen, but I am still here and still holding my now deeply discounted ALLP shares. Tom

To: A. Charles who wrote (530)	8/19/2001 9:27:51 PM
From: Oak Tree	Read Replies (1) \| Respond to of 548

I guess I don't think it will die either. The fluorinated hydrocarbons have advantages over the hemoglobin substitutes. Neither are anywhere near as good as good-old-fashioned blood however. Alliance could get rich if there is a war (and the army needs blood). Otherwise I'm not sure alliance will go anywhere. A big problem is (1) the trial had a bad design and therefore toxicity (and the control group did too well) (2) patients still need an O2 mask with fluorinated hydrocarbons -- hence its hard to manage on the battlefield. Good luck